Competitiveness in Biotechnology Advisory Group (CBAG) (E01315)

European Commission Expert GroupsDirectorate GeneralsEnterprise and Industry DG → Competitiveness in Biotechnology Advisory Group

Policy area(s)
Enterprise
Lead DG
Enterprise and Industry DG
Mission

A competitiveness in biotechnology advisory group with industry and academia to assist in identification of issues affecting European competitiveness. The group will provide input into the Commission’s regular reports on life sciences and biotechnology.

Task

Assist the Commission in the preparation of legislation or in policy definition

Group type
Formal, Permanent
Active since
14/06/06
Creating act
appointed by the Commission in 2003 in accordance with Action 10b of the Strategy (“Life sciences and biotechnology – A strategy for Europe”)
Composition
Corporate (Agriculture,Biodiversity,Biodiversity, Public health, Industrie alimentaire, Science, Chimie,Science, Industrie pharmaceutique)
Status
Active
Scope
Limited
Content last updated
16 Dec 2010
Register entry
http://ec.europa.eu/transparency/regexpert/detailGroup.cfm?groupID=1315

Organisation Group Members

AXXAM
BASF PLANT SCIENCE HOLDING GmbH
BIOVITRUM AB
Bayer CropScience AG
BioM
BioSeeds
DSM NV
EUROPABIO
EVOTEC OAI AG
FARON PHARMACEUTICALS
Flanders Interuniversity Institute for Biotechnology
GENZYME EUROPE
GLAXO SMITH & KLINE
INSTITUT PASTEUR
Institute of Biotechnology University of Cambridge
Istituto Scientifico H.S. Raffaele
LORANTIS LTD
MONSANTO Europe-Africa
MediGene AG
NOVARTIS PHARMA AG
NOVOZYMES A/S
SYNERGENES
SYNGENTA INTERNATIONAL AG
Scientific Advisory Group, CSIC
Tridelta plc
Università degli Studi di Siena

Created by @delineator to make it easier to browse data on European Commission Expert Groups.